SAN FRANSISCO, CA, Latent, the clinical-AI company accelerating access to life-saving medications, has raised an $80M Series A co-led by Spark Capital and Transformation Capital.
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.